Follow on Google News News By Tag * Systems Pharmacology * Mechanistic modeling * Pharmaceutical Industry * Drug Development * Biologicals * More Tags... Industry News * Pharmaceutical * More Industries... News By Place Country(s) Industry News
Follow on Google News | Dr. Dean Bottino, Roche, to Discuss Multi-scale Modeling in Development of Cancer Drugs in ImpDr. Bottino will present the Webinar “Multi-scale modeling to optimize the antitumor effect of antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced therapies” on June 19, 2013.
By: Rosa & Co According to Dr. Bottino, “Antibody- The dual mechanisms of action of ADCC-enhanced mAbs such as GA201 result in new and challenging drug development questions, for example: 1. Can we quantify the relative contributions of ADCC and target inhibition toward tumor shrinkage? 2. In light of (1), what markers (eg. KRAS mutation status, NK cell function) are predicted to confer sensitivity or resistance to the mAb? 3. Given observed kinetics of CD16+ cell depletion and recovery following administration of the mAb, what is the optimal schedule to optimize ADCC? 4. In the case of combination therapy with an immune-enhancing treatment, what dose and schedule would provide optimal synergy with the mAb’s ADCC effect? We propose a mathematical modeling framework for ADCC with the intention of addressing the questions posed above across several ADCC-relevant therapies. The proposed model would integrate clinically obtainable data sources, for example: FACS counts of (CD16+/56+) cells, NK cell function (CD107a, K562), tumor size (CT scan), mAb concentration in blood, and downstream target inhibition (eg pERK).” Register for this free webinar at http://www.rosaandco.com/ About Rosa Rosa informs our customer’s most critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of related issues, Rosa offers two customized approaches: classic pharmacokinetic/ More information can be found online at http://www.rosaandco.com Rosa and the Rosa logo are registered trademarks of Rosa & Co. LLC. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|